A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf.
Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination [Erratum]
2022
Clinical Ophthalmology
Preserved Fulltext
Contreras-Salinas H, Barajas-Hernández M, Baiza-Durán LM, Vázquez-Álvarez AO, Bautista-Castro MA, Rodríguez-Herrera LY. Clin Ophthalmol. 2021;15:583–590. On page 587, Table 3 was distorted during the correction stage and published in error. The correct Table 3 is shown in Download Article. Table 3 ADRs of TBD vs Reported by Individual Active Ingredient This error was introduced by the typesetting team during the editing process and was not picked up before publication. Read the original article
doaj:3f162001aa7e460c8f39fb92208efaab
fatcat:pyvtmfnburck7dmh46apdcam3e